Robert Alexander Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Alexander.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Alexander. Robert Alexander is Chief Executive Officer in ZS Pharma, Inc. ($ZSPH) and See Remarks in ZS Pharma, Inc. ($ZSPH) and Chief Executive Officer in Allakos Inc. ($ALLK) and President and CEO in Allakos Inc. ($ALLK) and Director in Allena Pharmaceuticals, Inc. ($ALNA).
Latest Insider Trading Transactions of Robert Alexander
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALLK, ALNA, ZSPH
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 0.69 | 14,517 | 9,980 | 985,083 | |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 0.69 | 14,517 | 9,980 | 970,566 | |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 0.69 | 14,516 | 9,980 | 956,050 | |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 0.69 | 14,517 | 9,980 | 259,912 | 245.4 K to 259.9 K (+5.92 %) |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Sell | S | 99.68 | 14,517 | 1,447,055 | 245,395 | 259.9 K to 245.4 K (-5.59 %) |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 0.69 | 14,517 | 9,980 | 259,912 | 245.4 K to 259.9 K (+5.92 %) |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Sell | S | 102.32 | 14,517 | 1,485,379 | 245,395 | 259.9 K to 245.4 K (-5.59 %) |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 0.69 | 14,516 | 9,980 | 259,911 | 245.4 K to 259.9 K (+5.92 %) |
May 19 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Sell | S | 98.94 | 14,516 | 1,436,213 | 245,395 | 259.9 K to 245.4 K (-5.58 %) |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 0.69 | 20,000 | 13,750 | 1,039,600 | |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 0.69 | 20,000 | 13,750 | 1,019,600 | |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 0.69 | 20,000 | 13,750 | 999,600 | |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 0.69 | 20,000 | 13,750 | 265,395 | 245.4 K to 265.4 K (+8.15 %) |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Sell | S | 122.78 | 20,000 | 2,455,600 | 245,395 | 265.4 K to 245.4 K (-7.54 %) |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 0.69 | 20,000 | 13,750 | 265,395 | 245.4 K to 265.4 K (+8.15 %) |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Sell | S | 121.76 | 20,000 | 2,435,200 | 245,395 | 265.4 K to 245.4 K (-7.54 %) |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 0.69 | 20,000 | 13,750 | 265,395 | 245.4 K to 265.4 K (+8.15 %) |
Mar 17 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Sell | S | 121.14 | 20,000 | 2,422,800 | 245,395 | 265.4 K to 245.4 K (-7.54 %) |
Mar 03 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Payment of Exercise | F | 117.82 | 3,890 | 458,320 | 245,395 | 249.3 K to 245.4 K (-1.56 %) |
Mar 03 2021 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Payment of Exercise | F | 117.82 | 3,890 | 458,320 | 245,395 | 249.3 K to 245.4 K (-1.56 %) |
Dec 31 2020 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 4.31 | 8,240 | 35,535 | 306,960 | |
Dec 31 2020 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 4.31 | 8,240 | 35,535 | 306,960 | |
Dec 31 2020 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 4.31 | 8,240 | 35,535 | 241,105 | 232.9 K to 241.1 K (+3.54 %) |
Dec 31 2020 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 4.31 | 8,240 | 35,535 | 241,105 | 232.9 K to 241.1 K (+3.54 %) |
Nov 18 2020 | ALNA | Allena Pharmaceuti ... | Alexander Robert | Director | Option Exercise | A | 1.45 | 14,000 | 20,300 | 14,000 | |
Dec 03 2019 | ALLK | Allakos Inc. | Alexander Robert | Chief Executive Off ... | Grant | A | 0.00 | 121,600 | 0 | 124,377 | 2.8 K to 124.4 K (+4,378.83 %) |
Jun 07 2019 | ALNA | Allena Pharmaceuti ... | Alexander Robert | Director | Option Exercise | A | 5.59 | 14,000 | 78,260 | 14,000 | |
Oct 10 2018 | ALLK | Allakos Inc. | Alexander Robert | President and CEO | Option Exercise | A | 35.28 | 250,000 | 8,820,000 | 250,000 | |
Jun 12 2018 | ALNA | Allena Pharmaceuti ... | Alexander Robert | Director | Option Exercise | A | 13.52 | 10,182 | 137,661 | 10,182 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 55.57 | 73,201 | 4,067,780 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 55.57 | 1,799 | 99,970 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 27.16 | 74,748 | 2,030,156 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 27.16 | 2,864 | 77,786 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 5.62 | 132,473 | 743,968 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 5.62 | 39,566 | 222,203 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | D | 2.13 | 448,453 | 954,487 | 0 | |
Dec 21 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Sell | D | 90.00 | 30,750 | 2,767,500 | 0 | 30.8 K to 0 (-100.00 %) |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | M | 5.62 | 17,807 | 100,004 | 39,566 | |
Dec 10 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Buy | M | 5.62 | 17,807 | 100,004 | 17,807 | 0 to 17.8 K |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | See Remarks | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Jun 25 2015 | ZSPH | ZS Pharma, Inc. | Alexander Robert | See Remarks | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Jul 10 2014 | ZSPH | ZS Pharma, Inc. | Alexander Robert | Chief Executive Off ... | Option Exercise | A | 0.00 | 77,612 | 0 | 77,612 |
Page: 1